August Research Newsletter
Welcome to the August edition of Research News!
Please get in touch with any feedback or suggestions for future editions of Research News.
Featured Researchers: Dr Helen Pearson and Professor Richard Clarkson
We are proud to support a collaborative team led by Dr Helen Pearson and Professor Richard Clarkson at Cardiff University to develop and test a new drug targeting BCL3, that could offer a vital new treatment option for men with advanced prostate cancer.
Read more about the team's research and what it could mean for men.
Making Progress
We are really excited to announce that our Early Career Researcher (ECR) event Making Progress will be back on 2 April 2025 at the Royal College of Nursing, London.
If you're a lead applicant on a Prostate Cancer UK grant, keep an eye out for an email with a link for your ECRs to register.
If you're an ECR working on prostate cancer research, save the date and check the website regularly for updates including how to register.
Get ready for the event that will help you become the next leader in the field.
A targeted approach to unlock the potential of immunotherapy
Immunotherapy has revolutionised the treatment of many cancer types, but prostate cancer has been left behind.
Supported by a Prostate Cancer UK Research Innovation Award, a team led by Professor Claire Lewis from the University of Sheffield investigated if targeting immunotherapy to tumour immune cells could unlock the potential of these treatments.
Find out more about their hugely exciting new publication, which outlines how immunotherapy could help men benefit from hormone therapy for longer.
National Prostate Cancer Research Group
We've partnered with colleagues at Prostate Cancer Research to develop a proposal for a new National Prostate Cancer Research Group since the wind-down of NCRI in 2023.
Its really important this new group helps support the prostate cancer research community, to help make sure we achieve this we ask you to complete a short survey on our proposal. The survey should take no longer than 10 minutes to complete.
Funding opportunities – open now and coming soon
Research Innovation Awards - open now!
If you’ve got a novel, game-changing research project in mind, we want to hear from you! Our Research Innovation Awards grant scheme is open to Expressions of Interest, with a deadline of 8 October. This call is for bold, innovative research projects that have the real potential to impact the way prostate cancer is diagnosed and treated.
External Opportunity - NC3Rs Partnership and Impact awards
Awards of up to £200k (80% FEC) for up to 24 months are available to support researchers to work together to test and transfer 3Rs approaches between labs, accelerating the uptake of new approaches. Deadline 19 September. Learn more on the NC3Rs webpage.
You can read more about these schemes and find out about our other open funding calls in the link below.
TRANSFORM - Information on Digital Twin Biobank and for secondary NHS sites
During July we had two webinars from two of the researchers leading on our ground-breaking screening trial TRANSFORM. You can find out more about these webinars, including links to recordings, on our TRANSFORM webpage.
